You are here

  • Home
  • Archive
  • Volume 66, Issue 4
  • Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial

Article info

Article menu
Lung cancer
Original article
Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial
Free

Authors

  1. Correspondence to Barbara M Fischer, Department of Clinical Physiology and Nuclear Medicine, Hvidovre Hospital, section 239, Kettegaard Allé 30, 2650 Hvidovre, Denmark; bjerregaard.fischer{at}gmail.com
View Full Text

Citation

Fischer BM, Mortensen J, Hansen H, et al
Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial
Thorax 2011;66:294-300.

Publication history

  • Received November 4, 2010
  • Accepted November 11, 2010
  • First published December 17, 2010.
Online issue publication 
September 01, 2022

Article Versions

  • Web Only Data thx.2010.154476

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.